Metabolic syndrome and cardiovascular disease in South Asians

Vascular Health and Risk Management

Volumn 5, Issue , 2009, Pages 731-743

  Eapen, Danny ^a   Kalra, Girish L ^a   Merchant, Nadya ^a   Arora, Anjali ^b   Khan, Bobby V ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Orthopaedics   (India)

Author keywords

Cardiovascular disease; CVD; Heart disease; Metabolic syndrome; South Asians

Indexed keywords

ADIPOCYTOKINE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 6; INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; VASCULAR CELL ADHESION MOLECULE 1; VERY LOW DENSITY LIPOPROTEIN;

ABDOMINAL OBESITY; ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANTHROPOMETRY; BODY FAT; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; DEPRESSION; DIABETES MELLITUS; DIET; DYSLIPIDEMIA; ETHNIC GROUP; HEART INFARCTION; HEREDITY; HOME STRESS; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; JOB STRESS; LIFESTYLE; LIPID BLOOD LEVEL; MEDICAL LITERATURE; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOGENESIS; PRACTICE GUIDELINE; PREVALENCE; RACE DIFFERENCE; REVIEW; SOCIAL STATUS; SOUTH ASIA; UNSTABLE ANGINA PECTORIS; WAIST HIP RATIO;

ADULT; AGE OF ONSET; AGED; ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; ATTITUDE OF HEALTH PERSONNEL; CARDIOVASCULAR DISEASES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH STATUS DISPARITIES; HEALTH STATUS INDICATORS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS;

EID: 74049101691     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: None     Document Type: Review

References (144)

1. Yeolekar ME. Coronary artery disease in Asian Indians. J Postgrad Med. 1998;44(1):26-28.
2. Misra A, Misra R, Wijesuriya M, Banerjee D. The metabolic syndrome in South Asians: continuing escalation and possible solutions. Indian J Med Res. 2007;125(3):345-354.
3. Gupta M, Singh N, Verma S. South Asians and cardiovascular risk: what clinicians should know. Circulation. 2006;113(25):e924-e929.
4. Bernstein R. Minority Population Tops 100 million. US Census Bureau News. May 2007. http://www.census.gov/Press-Release/www/releases/archives/population/ 010048.html. Accessed June 2008.
5. Lindsay C. Profiles of Ethnic Communities in Canada: The South Asian Community in Canada: 2001. Statistics Canada. 2007. Catalogue no. 89-621-XIE. http://www.statcan.ca/english/freepub/89-621-XIE/89-621-XIE2007006. pdf. Accessed June 2008.
6. Reeves TJ. Bennett CE. We the People: Asians in the United States: Census 2000 Special Reports. Dec 2004. http://www.census.gov/prod/2004pubs/censr-17. pdf, Accessed June 2008.
7. Barnes JS, Bennett CE. The Asian Population: 2000. Census 2000 Brief. Feb 2002. http://www.census.gov/prod/2002pubs/c2kbr01-16.pdf. Accessed June 2008.
8. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Geneva: World Health Organization; 1999.
9. Grundy SM, Brewer HB Jr, Cleeman JI, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433-438.
10. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet. 2005;366(9491):1059-1062.
11. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16(5):442-443.
12. Lovegrove JA. CVD risk in South Asians: the importance of defining adiposity and influence of dietary polyunsaturated fat. Proc Nutr Soc. 2007;66(2):286-298.
13. Misra A, Vikram NK. Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications. Nutrition. 2004;20(5):482-491.
14. The World Bank. HNPStats: Population projection tables by country and group. http://go.worldbank.org/072F5QBOC0. Accessed June 2008.
15. Central Intelligence Agency. The World Factbook. 2008. https://www.cia.gov/library/publications/the-world-factbook/geos/in.html. Accessed June 2008.
16. Bhopal R, Unwin N, White M, et al. Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ. 1999;319(7204):215-220.
17. Patel S, Unwin N, Bhopal R, et al. A comparison of proxy measures of abdominal obesity in Chinese, European and South Asian adults. Diabet Med. 1999;16(10):853-860.
18. Palaniappan L, Wang Y, Fortmann SP. Coronary heart disease mortality for six ethnic groups in California, 1990-2000. Ann Epidemiol. 2004;14(7):499-506.
19. Sheth T, Nair C, Nargundkar M, Anand S, Yusuf S. Cardiovascular and cancer mortality among Canadians of European, south Asian and Chinese origin from 1979 to 1993: an analysis of 1.2 million deaths. CMAJ. 1999;161(2):132-138.
20. Harding S. Mortality of migrants from the Indian subcontinent to England and Wales: effect of duration of residence. Epidemiology. 2003;14(3):287-292.
21. McKeigue PM, Miller GJ, Marmot MG. Coronary heart disease in south Asians overseas: a review. J Clin Epidemiol. 1989;42(7):597-609.
22. Tuomilehto J, Ram P, Eseroma R, Taylor R, Zimmet P. Cardiovascular diseases and diabetes mellitus in Fiji: analysis of mortality, morbidity and risk factors. Bull World Health Organ. 1984;62(1):133-143.
23. World Health Organization. The World Health Report 2005. Preventing Chronic Diseases: A Vital Investment. Geneva: World Health Organization; 2005.
24. Joshi R, Cardona M, Iyengar S, et al. Chronic diseases now a leading cause of death in rural India - mortality data from the Andhra Pradesh Rural Health Initiative. Int J Epidemiol. 2006;35(6):1522-1529.
25. Xavier D, Pais P, Devereaux PJ, et al. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet. 2008;371(9622):1435-1442.
26. Joshi P, Islam S, Pais P, et al. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA. 2007;297(3):286-94.
27. Murray CJ, Lopez, AD. Global Comparative Assessments in the Health Sector. Geneva: World Health Organization; 1994.
28. Murray CJ, Lopez AD. Evidence-based health policy - lessons from the Global Burden of Disease Study. Science. 1996;274(5288):740-743.
29. Enas EA, Garg A, Davidson MA, Nair VM, Huet BA, Yusuf S. Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart J. 1996;48(4):343-353.
30. Dhawan J, Bray CL. Angiographic comparison of coronary artery disease between Asians and Caucasians. Postgrad Med J. 1994;70(827):625-630.
31. Gupta M, Singh N, Warsi M, Reiter M, Ali K. Canadian South Asians have more severe angiographic coronary disease than European Canadians despite having fewer risk factors. Can J Cardiol. 2001;17(Suppl C):226C.
32. McKeigue PM, Marmot MG. Mortality from coronary heart disease in Asian communities in London. BMJ. 1988;297(6653):903.
33. Singh N, Gupta M. Clinical characteristics of South Asian patients hospitalized with heart failure. Ethn Dis. 2005;15(4):615-619.
34. Gupta M, Doobay AV, Singh N, et al. Risk factors, hospital management and outcomes after acute myocardial infarction in South Asian Canadians and matched control subjects. CMAJ. 2002;166(6):717-722.
35. Wilkinson P, Sayer J, Laji K, et al. Comparison of case fatality in south Asian and white patients after acute myocardial infarction: observational study. BMJ. 1996;312(7042):1330-1333.
36. Patel JV, Lim HS, Gunarathne A, et al. Ethnic differences in myocardial infarction in patients with hypertension: effects of diabetes mellitus. QJM. 2008;101(3):231-236.
37. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217-223.
38. Mohan V, Mathur P, Deepa R, et al. Urban rural differences in prevalence of self-reported diabetes in India - the WHO-ICMR Indian NCD risk factor surveillance. Diabetes Res Clin Pract. 2008;80(1):159-168.
39. Sayeed MA, Mahtab H, Khanam PA, Latif ZA, Banu A, Khan AK. Prevalence of diabetes and impaired fasting glucose in urban population of Bangladesh. Bangladesh Med Res Counc Bull. 2007;33(1):1-12.
40. Petersen S, Peto V, Rayner M. Coronary Heart Disease Statistics. London, UK: British Heart Foundation; 2004.
41. Engelgau MM, Geiss LS, Saaddine JB, et al. The evolving diabetes burden in the United States. Ann Intern Med. 2004;140(11):945-950.
42. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21(4):518-524.
43. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289(1):76-79.
44. Venkataraman R, Nanda NC, Baweja G, Parikh N, Bhatia V. Prevalence of diabetes mellitus and related conditions in Asian Indians living in the United States. Am J Cardiol. 2004;94(7):977-980.
45. Anand SS, Yusuf S, Vuksan V, et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet. 2000;356(9226):279-284.
46. Enas EA, Yusuf S, Mehta JL. Prevalence of coronary artery disease in Asian Indians. Am J Cardiol. 1992;70(9):945-949.
47. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation. 2001;104(23):2855-2864.
48. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-952.
49. Gama R, Elfatih AB, Anderson NR. Ethnic differences in total and HDL cholesterol concentrations: Caucasians compared with predominantly Punjabi Sikh Indo-Asians. Ann Clin Biochem. 2002;39(Pt 6):609-611.
50. Hodge AM, Dowse GK, Collins VR, et al. Abdominal fat distribution and insulin levels only partially explain adverse cardiovascular risk profile in Asian Indians. J Cardiovasc Risk. 1996;3(3):263-270.
51. Hughes K, Aw TC, Kuperan P, Choo M. Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Community Health. 1997;51(4):394-399.
52. Kulkarni KR, Markovitz JH, Nanda NC, Segrest JP. Increased prevalence of smaller and denser LDL particles in Asian Indians. Arterioscler Thromb Vasc Biol. 1999;19(11):2749-2755.
53. Miller GJ, Beckles GL, Alexis SD, Byam NT, Price SG. Serum lipoproteins and susceptibility of men of Indian descent to coronary heart disease. The St. James Survey, Trinidad. Lancet. 1982;2(8291):200-203.
54. Miller GJ, Beckles GL, Maude GH, et al. Ethnicity and other characteristics predictive of coronary heart disease in a developing community: principal results of the St James Survey, Trinidad. Int J Epidemiol. 1989;18(4):808-817.
55. Tai ES, Emmanuel SC, Chew SK, Tan BY, Tan CE. Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia. Diabetes. 1999;48(5):1088-1092.
56. Misra A, Luthra K, Vikram NK. Dyslipidemia in Asian Indians: determinants and significance. J Assoc Physicians India. 2004;52:137-142.
57. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet. 1991;337(8738):382-386.
58. Lubree HG, Rege SS, Bhat DS, et al. Body fat and cardiovascular risk factors in Indian men in three geographical locations. Food Nutr Bull. 2002;23(3 Suppl):146-149.
59. Reddy KS. Primordial prevention of coronary heart disease in India: challenges and opportunities. Prev Med. 1999;29(6 Pt 2):S119-S123.
60. Reddy KK, Ramachandraiah T, Reddanna P, Thyagaraju K. Serum lipid peroxides and lipids in urban and rural Indian men. Arch Environ Health. 1994;49(2):123-127.
61. Rastogi T, Vaz M, Spiegelman D, et al. Physical activity and risk of coronary heart disease in India. Int J Epidemiol. 2004;33(4):759-767.
62. Physical activity and cardiovascular health. NIH Consensus Development Panel on Physical Activity and Cardiovascular Health. JAMA. 1996;276(3):241-246.
63. Hambrecht R, Wolf A, Gielen S, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med. 2000;342(7):454-460.
64. Rosengren A, Wilhelmsen L. Physical activity protects against coronary death and deaths from all causes in middle-aged men. Evidence from a 20-year follow-up of the primary prevention study in Goteborg. Ann Epidemiol. 1997;7(1):69-75.
65. Wannamethee SG, Shaper AG, Alberti KG. Physical activity, metabolic factors, and the incidence of coronary heart disease and type 2 diabetes. Arch Intern Med. 2000;160(14):2108-2116.
66. Abraham R, Brown MC, North WR, McFadyen IR. Diets of Asian pregnant women in Harrow: iron and vitamins. Hum Nutr Appl Nutr. 1987;41(3):164-173.
67. Dawson DW, Waters HM. Malnutrition: folate and cobalamin deficiency. Br J Biomed Sci. 1994;51(3):221-227.
68. Matthews JH, Wood JK. Megaloblastic anaemia in vegetarian Asians. Clin Lab Haematol. 1984;6(1):1-7.
69. Joshipura KJ, Hu FB, Manson JE, et al. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med. 2001;134(12):1106-1114.
70. Krauss RM, Deckelbaum RJ, Ernst N, et al. Dietary guidelines for healthy American adults. A statement for health professionals from the Nutrition Committee, American Heart Association. Circulation. 1996;94(7):1795-1800.
71. Panagiotakos DB, Pitsavos C, Kokkinos P, et al. Consumption of fruits and vegetables in relation to the risk of developing acute coronary syndromes; the CARDIO2000 case-control study. Nutr J. 2003;2:2.
72. van't Veer P, Jansen MC, Klerk M, Kok FJ. Fruits and vegetables in the prevention of cancer and cardiovascular disease. Public Health Nutr. 2000;3(1):103-107.
73. Bhopal R, Hayes L, White M, et al. Ethnic and socio-economic inequalities in coronary heart disease, diabetes and risk factors in Europeans and South Asians. J Public Health Med. 2002;24(2):95-105.
74. Durrington PN, Livingstone S, Charlton-Menys V. Apolipoproteins as predictors of cardiovascular risk in the Collaborative Atorvastin Diabetes Study (CARDS) [abstract]. Atherosclerosis. 2006;7(Suppl 37):Mo-W14:14.
75. Olsson AG, Holme I, Pedersen, T. Apolipoprotein B/A1 ratio is a better discriminator of risk of coronary heart disease than is LDL/HDL-cholesterol ratio in the IDEAL study. Atherosclerosis. 2006;7(Suppl):161.
76. Pedersen TR, Faergeman O, Kastelein JJ, et al. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA. 2005;294(19):2437- 2445.
77. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet. 2001;358(9298):2026-2033.
78. Walldius G, Junger, I. The apoB/apo A-1 ratio- a new predictor of fatal stroke, myocardial infarction and other ischaemic diseases- stronger than LDL and lipid ratios. Atherosclerosis. 2006;7(Suppl):468.
79. Enas EA, Dhawan J, Petkar S. Coronary artery disease in Asian Indians: lessons learnt and the role of lipoprotein(a). Indian Heart J. 1997;49(1):25-34.
80. Enas EA, Mehta J. Malignant coronary artery disease in young Asian Indians: thoughts on pathogenesis, prevention, and therapy. Coronary Artery Disease in Asian Indians (CADI) Study. Clin Cardiol. 1995;18(3):131-135.
81. Enas EA, Mehta JL. Lipoprotein (a): an important risk factor in coronary artery disease. J Am Coll Cardiol. 1998;32(4):1132-1134.
82. Gambhir JK, Kaur H, Gambhir DS, Prabhu KM. Lipoprotein(a) as an independent risk factor for coronary artery disease in patients below 40 years of age. Indian Heart J. 2000;52(4):411-415.
83. Gupta R, Kastia S, Rastogi S, Kaul V, Nagar R, Enas EA. Lipoprotein(a) in coronary heart disease: a case-control study. Indian Heart J. 2000;52(4):407-410.
84. Anand SS, Enas EA, Pogue J, Haffner S, Pearson T, Yusuf S. Elevated lipoprotein(a) levels in South Asians in North America. Metabolism. 1998;47(2):182-184.
85. Haffner SM, Gruber KK, Morales PA, et al. Lipoprotein(a) concentrations in Mexican Americans and non-Hispanic whites: the San Antonio Heart Study. Am J Epidemiol. 1992;136(9):1060-1068.
86. Howard BV, Le NA, Belcher JD, et al. Concentrations of Lp(a) in black and white young adults: relations to risk factors for cardiovascular disease. Ann Epidemiol. 1994;4(5):341-350.
87. Wang W, Hu D, Lee ET, et al. Lipoprotein(a) in American Indians is low and not independently associated with cardiovascular disease. The Strong Heart Study. Ann Epidemiol. 2002;12(2):107-114.
88. Bhatnagar D, Anand IS, Durrington PN, et al. Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India. Lancet. 1995;345(8947):405-409.
89. Hoogeveen RC, Gambhir JK, Gambhir DS, et al. Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts. J Lipid Res. 2001;42(4):631-638.
90. Desmarais RL, Sarembock IJ, Ayers CR, Vernon SM, Powers ER, Gimple LW. Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty. Circulation. 1995;91(5):1403-1409.
91. Hoff HF, Beck GJ, Skibinski CI, et al. Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation. 1988;77(6):1238-1244.
92. von Eckardstein A, Schulte H, Cullen P, Assmann G. Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk. J Am Coll Cardiol. 2001;37(2):434-439.
93. Hopkins PN, Wu LL, Hunt SC, James BC, Vincent GM, Williams RR. Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease. Arterioscler Thromb Vasc Biol. 1997;17(11):2783-2792.
94. Solymoss BC, Marcil M, Wesolowska E, Gilfix BM, Lesperance J, Campeau L. Relation of coronary artery disease in women <60 years of age to the combined elevation of serum lipoprotein (a) and total cholesterol to high-density cholesterol ratio. Am J Cardiol. 1993;72(17):1215-1219.
95. Anand SS, Razak F, Yi Q, et al. C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler Thromb Vasc Biol. 2004;24(8):1509-1515.
96. Chambers JC, Eda S, Bassett P, et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation. 2001;104(2):145-150.
97. Deepa R, Velmurugan K, Arvind K, et al. Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance - the Chennai Urban Rural Epidemiology Study (CURES). Metabolism. 2006;55(9):1232-1238.
98. Liew CF, Seah ES, Yeo KP, Lee KO, Wise SD. Lean, nondiabetic Asian Indians have decreased insulin sensitivity and insulin clearance, and raised leptin compared to Caucasians and Chinese subjects. Int J Obes Relat Metab Disord. 2003;27(7):784-789.
99. Raji A, Gerhard-Herman MD, Warren M, et al. Insulin resistance and vascular dysfunction in nondiabetic Asian Indians. J Clin Endocrinol Metab. 2004;89(8):3965-3972.
100. Snehalatha C, Mukesh B, Simon M, Viswanathan V, Haffner SM, Ramachandran A. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians. Diabetes Care. 2003;26(12):3226-3229.
101. Gheye S, Lakshmi AV, Krishna TP, et al. Fibrinogen and homocysteine levels in coronary artery disease. Indian Heart J. 1999;51(5):499-502.
102. Chambers JC, Obeid OA, Refsum H, et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet. 2000;355(9203):523-527.
103. Chandalia M, Abate N, Cabo-Chan AV Jr, et al. Hyperhomocysteinemia in Asian Indians living in the United States. J Clin Endocrinol Metab. 2003;88(3):1089-1095.
104. Chambers JC, McGregor A, Jean-Marie J, et al. Abnormalities of vascular endothelial function may contribute to increased coronary heart disease risk in UK Indian Asians. Heart. 1999;81(5):501-504.
105. Vega GL. Results of Expert Meetings: Obesity and Cardiovascular Disease. Obesity, the metabolic syndrome, and cardiovascular disease. Am Heart J. 2001;142(6):1108-1116.
106. Misra A. We need ethnic-specific criteria for classification of BMI. In: Mediros-Neto G, Halpern A, Bouchard C, editors. Progress in Obesity Research. Vol 9: John Libbey Eurotext Ltd.; 2003. p. 547.
107. Wang CC, Goalstone ML, Draznin B. Molecular mechanisms of insulin resistance that impact cardiovascular biology. Diabetes. 2004;53(11):2735-2740.
108. Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab. 1999;84(1):137-144.
109. Targher G, Bertolini L, Poli F, et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes. 2005;54(12):3541-3546.
110. Mohan V, Farooq S, Deepa M, et al. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res Clin Pract. 2009;84(1):84-91.
111. Deepa M, Farooq S, Datta M, Deepa R, Mohan V. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev. 2007;23(2):127-134.
112. Miller GJ, Kotecha S, Wilkinson WH, et al. Dietary and other characteristics relevant for coronary heart disease in men of Indian, West Indian and European descent in London. Atherosclerosis. 1988;70(1-2):63-72.
113. Sharp PS, Mohan V, Levy JC, Mather HM, Kohner EM. Insulin resistance in patients of Asian Indian and European origin with noninsulin dependent diabetes. Horm Metab Res. 1987;19(2):84-85.
114. Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord. 1998;22(12):1164-1171.
115. Dudeja V, Misra A, Pandey RM, Devina G, Kumar G, Vikram NK. BMI does not accurately predict overweight in Asian Indians in northern India. Br J Nutr. 2001;86(1):105-112.
116. Misra A. Body composition and the metabolic syndrome in Asian Indians: a saga of multiple adversities. Natl Med J India. 2003;16(1):3-7.
117. Misra A, Athiko D, Sharma R, Pandey RM, Khanna N. Non-obese hyperlipidemic Asian northern Indian males have adverse anthropometric profile. Nutr Metab Cardiovasc Dis. 2002;12(4):178-183.
118. Yajnik CS. The lifecycle effects of nutrition and body size on adult adiposity, diabetes and cardiovascular disease. Obes Rev. 2002;3(3):217-224.
119. Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab. 1999;84:2329-2935.
120. Chowdhury B, Lantz H, Sjostrom L. Computed tomography-determined body composition in relation to cardiovascular risk factors in Indian and matched Swedish males. Metabolism. 1996;45(5):634-644.
121. Kalhan R, Puthawala K, Agarwal S, Amini SB, Kalhan SC. Altered lipid profile, leptin, insulin, and anthropometry in offspring of South Asian immigrants in the United States. Metabolism. 2001;50(10):1197-1202.
122. Kamath SK, Hussain EA, Amin D, et al. Cardiovascular disease risk factors in 2 distinct ethnic groups: Indian and Pakistani compared with American premenopausal women. Am J Clin Nutr. 1999;69(4):621-631.
123. Mohan V, Deepa M, Farooq S, Narayan KM, Datta M, Deepa R. Anthropometric cut points for identification of cardiometabolic risk factors in an urban Asian Indian population. Metabolism. 2007;56(7):961-968.
124. Razak F, Anand SS, Shannon H, et al. Defining obesity cut points in a multiethnic population. Circulation. 2007;115(16):2111-2118.
125. Forouhi NG, Jenkinson G, Thomas EL, et al. Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men. Diabetologia. 1999;42(8):932-935.
126. Jafar TH, Chaturvedi N, Pappas G. Prevalence of overweight and obesity and their association with hypertension and diabetes mellitus in an Indo-Asian population. CMAJ. 2006;175(9):1071-1077.
127. Lear SA, Toma M, Birmingham CL, Frohlich JJ. Modification of the relationship between simple anthropometric indices and risk factors by ethnic background. Metabolism. 2003;52(10):1295-1301.
128. Lovegrove JA, Brady LM, Lesauvage SV, Lovegrove SS, Minihane AM, Williams CM. Lack of association between central adiposity and lipaemia in UK Sikh men. Int J Obes Relat Metab Disord. 2003;27(11):1373-1382.
129. Unwin N, Harland J, White M, et al. Body mass index, waist circumference, waist-hip ratio, and glucose intolerance in Chinese and Europid adults in Newcastle, UK. J Epidemiol Community Health. 1997;51(2):160-166.
130. WHO/IASO/IOTF. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Melbourne: Health Communications Australia; 2000.
131. Misra A, Vikram NK, Gupta R, Pandey RM, Wasir JS, Gupta VP. Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity. Int J Obes (Lond). 2006;30(1):106-111.
132. Genuth S, Alberti KG, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26(11):3160-3167.
133. Whincup PH, Gilg JA, Papacosta O, et al. Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children. BMJ. 2002;324(7338):635.
134. Whincup PH, Gilg JA, Owen CG, Odoki K, Alberti KG, Cook DG. British South Asians aged 13-16 years have higher fasting glucose and insulin levels than Europeans. Diabet Med. 2005;22(9):1275-1277.
135. Mohan B, Kumar N, Aslam N, et al. Prevalence of sustained hypertension and obesity in urban and rural school going children in Ludhiana. Indian Heart J. 2004;56(4):310-314.
136. Yajnik CS, Lubree HG, Rege SS, et al. Adiposity and hyperinsulinemia in Indians are present at birth. J Clin Endocrinol Metab. 2002;87(12):5575-5580.
137. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005;115(3):e290-e296.
138. Hofman PL, Cutfield WS, Robinson EM, et al. Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab. 1997;82(2):402-406.
139. Bavdekar A, Yajnik CS, Fall CH, et al. Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both? Diabetes. 1999;48(12):2422-2429.
140. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia. 1993;36(1):62-67.
141. Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992;35(7):595-601.
142. Yajnik C. Interactions of perturbations in intrauterine growth and growth during childhood on the risk of adult-onset disease. Proc Nutr Soc. 2000;59(2):257-265.
143. Goodman E, Daniels SR, Morrison JA, Huang B, Dolan LM. Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr. 2004;145(4):445-451.
144. Vikram NK, Misra A, Pandey RM, Luthra K, Wasir JS, Dhingra V. Heterogeneous phenotypes of insulin resistance and its implications for defining metabolic syndrome in Asian Indian adolescents. Atherosclerosis. 2006;186(1):193-199.